Cargando…
Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613878/ https://www.ncbi.nlm.nih.gov/pubmed/34840710 http://dx.doi.org/10.1177/20406223211055922 |
| _version_ | 1784603737004703744 |
|---|---|
| author | Guan, Jin-Tao Wang, Wei-Jie Lei, Shan-Shan Xu, Zheng-Hao |
| author_facet | Guan, Jin-Tao Wang, Wei-Jie Lei, Shan-Shan Xu, Zheng-Hao |
| author_sort | Guan, Jin-Tao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8613878 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86138782021-11-26 Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’ Guan, Jin-Tao Wang, Wei-Jie Lei, Shan-Shan Xu, Zheng-Hao Ther Adv Chronic Dis Letter to the Editor SAGE Publications 2021-11-21 /pmc/articles/PMC8613878/ /pubmed/34840710 http://dx.doi.org/10.1177/20406223211055922 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Guan, Jin-Tao Wang, Wei-Jie Lei, Shan-Shan Xu, Zheng-Hao Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’ |
| title | Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’ |
| title_full | Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’ |
| title_fullStr | Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’ |
| title_full_unstemmed | Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’ |
| title_short | Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’ |
| title_sort | author response to: correspondence to: ‘a meta-analysis of granulocyte-macrophage colony-stimulating factor (gm-csf) antibody treatment for covid-19 patients’ |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613878/ https://www.ncbi.nlm.nih.gov/pubmed/34840710 http://dx.doi.org/10.1177/20406223211055922 |
| work_keys_str_mv | AT guanjintao authorresponsetocorrespondencetoametaanalysisofgranulocytemacrophagecolonystimulatingfactorgmcsfantibodytreatmentforcovid19patients AT wangweijie authorresponsetocorrespondencetoametaanalysisofgranulocytemacrophagecolonystimulatingfactorgmcsfantibodytreatmentforcovid19patients AT leishanshan authorresponsetocorrespondencetoametaanalysisofgranulocytemacrophagecolonystimulatingfactorgmcsfantibodytreatmentforcovid19patients AT xuzhenghao authorresponsetocorrespondencetoametaanalysisofgranulocytemacrophagecolonystimulatingfactorgmcsfantibodytreatmentforcovid19patients |